Blurbs

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Envista Holdings (NVST) and TELA Bio (TELA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on DENTSPLY SIRONA (XRAYResearch Report), Envista Holdings (NVSTResearch Report) and TELA Bio (TELAResearch Report) with bullish sentiments.

DENTSPLY SIRONA (XRAY)

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on DENTSPLY SIRONA, with a price target of $44.00. The company’s shares closed last Wednesday at $36.27, close to its 52-week low of $33.78.

According to TipRanks.com, Wright is a 5-star analyst with an average return of 17.2% and a 65.7% success rate. Wright covers the Healthcare sector, focusing on stocks such as Idexx Laboratories, SmileDirectClub, and Align Tech.

Currently, the analyst consensus on DENTSPLY SIRONA is a Moderate Buy with an average price target of $44.09.

See the top stocks recommended by analysts >>

Envista Holdings (NVST)

Morgan Stanley analyst Drew Ranieri maintained a Buy rating on Envista Holdings today and set a price target of $53.00. The company’s shares closed last Wednesday at $40.33.

According to TipRanks.com, Ranieri is a 1-star analyst with an average return of -7.1% and a 40.0% success rate. Ranieri covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Baxter International, and Intuitive Surgical.

Envista Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $51.00.

TELA Bio (TELA)

JMP Securities analyst David Turkaly reiterated a Buy rating on TELA Bio today and set a price target of $22.00. The company’s shares closed last Wednesday at $8.01.

According to TipRanks.com, Turkaly is a 3-star analyst with an average return of 2.9% and a 42.0% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and OrthoPediatrics.

TELA Bio has an analyst consensus of Moderate Buy, with a price target consensus of $19.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on XRAY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos